Back to search

Article

A Real-life Study of the Positive Response to DAA-based Therapies for Hepatitis C in Brazil

2020-10-08

Abstract excerpt

Treating hepatitis C virus (HCV) infections reduces overall mortality and the risk of multiple extrahepatic complications. Direct-acting antivirals (DAAs) are molecules that target specific non-structural proteins of the virus, resulting in the disruption of viral replication and infection. This report describes the activities undertaken to assess the cure of HCV in patients of different age groups, supported by t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3628fbf6-0bab-5bde-95f3-f8012ede21c8
DOI
10.1101/2020.10.06.20207274
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Real-life Study of the Positive Response to DAA-based Therapies for Hepatitis C in BrazilDOI 10.1101/2020.10.06.20207274
A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil.Semantic proximity
Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil.Semantic proximity
National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents.Semantic proximity
A real-life study on the impact of direct-acting antivirals in the treatment of chronic hepatitis C in liver transplant recipients at two university centers in Northeastern Brazil.Semantic proximity
Treatment of HCV infection with direct-acting antiviral agents. Real life experiences from the Euro-Asian region.Semantic proximity
Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV).Semantic proximity
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results.Semantic proximity
Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China.Semantic proximity
Experience with direct-acting antivirals in genotype 1-5 infected chronic hepatitis C patients in Turkey.Semantic proximity
Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil.Semantic proximity
Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.Semantic proximity
Direct-acting antiviral agents in patients with hepatitis C genotype 1-4 infections in a tertiary hospital.Semantic proximity
Select a neighboring publication to make it the new centre.